Compassionate use programs or phase IV trials of innovative molecular targeted drugs in lung cancer: deal or no deal?
- PMID: 20871257
- DOI: 10.1097/JTO.0b013e3181f41b1c
Compassionate use programs or phase IV trials of innovative molecular targeted drugs in lung cancer: deal or no deal?
Comment on
-
Efficacy and safety of erlotinib in 1242 East/South-East Asian patients with advanced non-small cell lung cancer.J Thorac Oncol. 2010 Oct;5(10):1609-15. doi: 10.1097/JTO.0b013e3181e15d55. J Thorac Oncol. 2010. PMID: 20808255 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical